Clinical Trials Browser

INDUSTRY × Tirapazamine × Gastrointestinal × Clear all

NCT06848556 2025-02-27

Evaluate the Effect of Tirazamine on Primary Liver Cancer.

Phase 1/2 Terminated

Gastrointestinal

Carcinoma, Hepatocellular

NCT02174549 2024-11-22

Dose-defining Study of Tirapazamine Combined With Embolization in Liver Cancer

Phase 1/2 Recruiting

EndocrineGastrointestinalNET

Hypoxia, Carcinoma, Hepatocellular, Neuroendocrine Tumors

NCT03145558 2024-11-22

TATE

Phase 2 Terminated

Gastrointestinal

Carcinoma, Hepatocellular